«We anticipate,» says Dr. Chou, «that this research will provide important pre-clinical data to support clinical trials using DAC and similar drugs combined with immune therapies targeting antigens like NY - ESO - 1 to treat advanced colorectal cancer and potentially other common cancers.» (cancerresearch.org)
Hospital and other health care costs for prostate, breast, liver colorectal, lung and other common cancers cost San Franciscans about $ 213 million annually. (ucsf.edu)
Tulane University researchers have discovered that the protein PHLDB3, thought to be a potential tumor suppressor, actually allows cancer cells to thrive in pancreatic, prostate, colon, breast, lung, and other common cancers. (sciencedaily.com)